HOWE JILL ANN (Chief Financial Officer) purchased 142.9% of their position (15K shares) of LINEAGE CELL THERAPEUTICS, INC. on the open market
Open‑market purchase worth $8.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/26/2024ACC: 0000950170-24-131098
Officer· Chief Financial Officer
Since Mar 2026
+15K
Net shares
Net buyer
$8.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
15K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+15K
Price / share
$0.59
Trade value
$8.85K
% of position
142.9%
11/26/2024
10.50K→25.50K
Total
Net shares
+15K
Net value
$8.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 11/26/2024 | P · Purchase | +15K | $0.59 | $8.85K | 142.9% | 10.50K | 25.50K |
| Total | +15K | $8.85K | ||||||
Derivative Transactions0
No derivative transactions reported